News | December 31, 2014

Investors Express Confidence in Innovative Cardiovascular Solutions' Emblok Embolic Protection Catheter with $5 Million Financing

Designed to be utilized in TAVR

December 31, 2014 — Innovative Cardiovascular Solutions LLC has completed a Class A Unit financing totaling $5 million to fund its Emblok Embolic Protection Catheter. It is designed to be utilized in transaortic valve replacement (TAVR) procedures as well as several other left heart interventional procedures where embolic protection would be required.

The Emblok device offers full circumferential aortic collection while protecting the cerebral, abdominal and peripheral vasculature from embolic debris. The design of the Emblok system allows the physician constant visualization during the procedure and aids in precise valve implantation while eliminating the need for constant dye injections to verify positioning.

 


Additional Content

News | Embolic Protection Devices

April 25, 2023 — FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the ...

Home April 25, 2023
Home
News | Embolic Protection Devices

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

Home January 11, 2023
Home
News | Embolic Protection Devices

September 17, 2022 — Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial ...

Home September 17, 2022
Home
News | Embolic Protection Devices

February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke ...

Home February 09, 2021
Home
News | Embolic Protection Devices

August 6, 2019 — Cardiovascular Systems Inc. (CSI) has acquired the Wirion Embolic Protection System and related assets ...

Home August 06, 2019
Home
Subscribe Now